HBV, HCV
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. The two viruses share same modes of transmission, coinfection is not uncommon, especially among high risk populations.
Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review.
Complementary therapies are widely promoted for and used by patients with hepatitis C. The aim of this article was to systematically assess the efficacy of complementary therapies in treating chronic hepatitis C.
How Does Coffee Prevent Liver Fibrosis? Biological Plausibility for Recent Epidemiological Observations
The published epidemiological data demonstrates an inverse relationship between coffee (and potentially other caffeinated beverage) consumption and liver fibrosis and its downstream complications are weighty and rapidly accumulating. Several excellent recent reviews examine this evidence in great detail, and the overwhelming conclusion is that this inverse relationship is real—coffee drinking reduces liver fibrosis.
Hepatitis C - Epidemiology and Review of Complementary/Alternative Medicine Treatments
The hepatic damage is due both to the cytopathic effect of the virus and the inflammatory changes secondary to immune activation. The use of the botanical components glycyrrhizin, catechin, silymarin and phytosterols, and the antioxidants N-acetylcysteine and vitamin E are reviewed for their efficacy in treating chronic hepatitis and affecting liver damage.
Hepatitis C Focus on Dietary Supplements
Conventional medical treatments are available for chronic hepatitis C. Some people with hepatitis C also try complementary health approaches, especially dietary supplements. This fact sheet provides basic information on hepatitis C, summarizes scientific research on selected supplements, and suggests sources for additional information.
Marijuana does not Accelerate Liver Disease in HIV–HCV Coinfection
Marijuana smoking is common and believed to relieve many symptoms, but daily use has been associated with liver fibrosis in cross-sectional studies. We aimed to estimate the effect of marijuana smoking on liver disease progression in a Canadian prospective multicenter cohort of HIV/HCV co-infected persons.
Increased Intake of Vegetables, but not Fruit, Reduces Risk for HepatocellularCarcinoma: A Meta-analysis
Based on a meta-analysis, increased intake of vegetables, but not fruit, is associated with lower risk for HCC. The risk of HCC decreases by 8% for every 100g/day increase in vegetable intake. The findings should be confirmed by future studies with validated questionnaires and strict control of confounders.
The Top Three Alternative Treatments for Hepatitis C
For those who are not able to conquer the Hepatitis C virus with combination therapy, discover three holistic approaches that can help improve your treatment odds and/or stave off liver damage.
Decline in incidence of HIV and hepatitis C virusinfection among injecting drug users in Amsterdam;evidence for harm reduction?
In Amsterdam, HIV prevalence has nearly halved among injecting drug users (IDU) since 1990. Hepatitis C virus (HCV) prevalence also declined; HIV and HCV incidence dropped to nearly zero. We examined possible explanations for these time trends, among which the implementation of harm reduction measures aimed at reducing the risk behaviour of IDU.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between 1990 and 2013.
Estimates on HCV Disease Burden Worldwide - filling the gaps
As resources are limited, solid data to estimate the disease burden caused by HCV are urgently needed. Epidemiology data and disease burden analyses for 16 countries are presented.
